vs
Side-by-side financial comparison of Avidia Bancorp, Inc. (AVBC) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $26.8M, roughly 1.8× Avidia Bancorp, Inc.). Avidia Bancorp, Inc. runs the higher net margin — 22.9% vs -2.1%, a 25.1% gap on every dollar of revenue. Avidia Bancorp, Inc. produced more free cash flow last quarter ($24.1M vs $6.9M).
Avidia Bank is an American mutual community bank headquartered in Hudson, Massachusetts. It was founded in 2007 when it was formed by a merger between Hudson Savings Bank and Westborough Bank.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
AVBC vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $26.8M | $49.0M |
| Net Profit | $5.3M | $-1.1M |
| Gross Margin | — | 53.5% |
| Operating Margin | 33.3% | 2.1% |
| Net Margin | 22.9% | -2.1% |
| Revenue YoY | — | 32.3% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.8M | $49.0M | ||
| Q3 25 | $28.0M | $39.8M | ||
| Q2 25 | $25.9M | $35.1M | ||
| Q1 25 | $22.9M | $33.3M | ||
| Q4 24 | — | $37.1M |
| Q4 25 | $5.3M | $-1.1M | ||
| Q3 25 | $-907.0K | $-3.5M | ||
| Q2 25 | $3.9M | $-3.0M | ||
| Q1 25 | $-11.6M | $-3.0M | ||
| Q4 24 | — | $-1.1M |
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 52.1% |
| Q4 25 | 33.3% | 2.1% | ||
| Q3 25 | -7.0% | -3.6% | ||
| Q2 25 | 19.4% | -5.2% | ||
| Q1 25 | -72.0% | -3.0% | ||
| Q4 24 | — | 1.2% |
| Q4 25 | 22.9% | -2.1% | ||
| Q3 25 | -3.2% | -8.9% | ||
| Q2 25 | 15.0% | -8.6% | ||
| Q1 25 | -50.5% | -9.1% | ||
| Q4 24 | — | -2.9% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.05 | $-0.07 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $275.0M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $379.0M | $113.0M |
| Total Assets | $2.8B | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $275.0M | $10.5M | ||
| Q3 25 | $208.3M | $12.9M | ||
| Q2 25 | $592.5M | $11.3M | ||
| Q1 25 | — | $17.1M | ||
| Q4 24 | — | $15.5M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $87.6M | ||
| Q2 25 | — | $66.0M | ||
| Q1 25 | — | $71.5M | ||
| Q4 24 | — | $70.6M |
| Q4 25 | $379.0M | $113.0M | ||
| Q3 25 | $372.0M | $112.1M | ||
| Q2 25 | $191.4M | $102.5M | ||
| Q1 25 | $186.1M | $103.6M | ||
| Q4 24 | — | $106.3M |
| Q4 25 | $2.8B | $280.7M | ||
| Q3 25 | $2.8B | $283.3M | ||
| Q2 25 | $3.0B | $236.1M | ||
| Q1 25 | $2.7B | $244.6M | ||
| Q4 24 | — | $242.8M |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.4M | $8.9M |
| Free Cash FlowOCF − Capex | $24.1M | $6.9M |
| FCF MarginFCF / Revenue | 89.9% | 14.0% |
| Capex IntensityCapex / Revenue | 16.0% | 4.2% |
| Cash ConversionOCF / Net Profit | 5.32× | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.2M | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.4M | $8.9M | ||
| Q3 25 | $24.1M | $9.8M | ||
| Q2 25 | $-2.3M | $9.7M | ||
| Q1 25 | $-2.2M | $8.9M | ||
| Q4 24 | — | $9.3M |
| Q4 25 | $24.1M | $6.9M | ||
| Q3 25 | $23.3M | $8.0M | ||
| Q2 25 | $-3.3M | $4.4M | ||
| Q1 25 | $-3.9M | $7.3M | ||
| Q4 24 | — | $5.6M |
| Q4 25 | 89.9% | 14.0% | ||
| Q3 25 | 83.2% | 20.0% | ||
| Q2 25 | -12.8% | 12.6% | ||
| Q1 25 | -16.9% | 22.0% | ||
| Q4 24 | — | 15.2% |
| Q4 25 | 16.0% | 4.2% | ||
| Q3 25 | 3.1% | 4.6% | ||
| Q2 25 | 3.7% | 14.9% | ||
| Q1 25 | 7.2% | 4.8% | ||
| Q4 24 | — | 9.9% |
| Q4 25 | 5.32× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.60× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
